Pegfilgrastim Injection

Name: Pegfilgrastim Injection
Brand: NEETCO BIOPHARMA
Price: 1999 INR
Availability: InStock

Price 1999 INR/ Pack

Get a Price/Quote

MOQ : 1 Pack

Pegfilgrastim Injection Specification

Dosage Form
Injection

Indication
Prevention of chemotherapy-induced neutropenia

Salt Composition
Pegfilgrastim

Enzyme Types
Recombinant human granulocyte colony-stimulating factor

Feature
Long-acting single-dose, polyethylene glycol conjugated

Ingredients
Pegfilgrastim, excipients

Application
Subcutaneous injection for oncology/supportive care

Ph Level
Approximately 4.0 to 5.0

Temperature Needed For Fermentation
Produced in controlled fermentation at 30-37C

Physical Color/Texture
Clear, colorless solution

Fermentation Smell
Odorless

Enzymatic Activity
Stimulates neutrophil proliferation and differentiation

Storage Instructions
Store refrigerated at 2C8C, do not freeze

Shelf Life
24 months

Registration
Subject to regulatory approval by CDSCO/USFDA

USP Compliance
Meets relevant pharmacopeial standards

Primary Action
Reduces duration and incidence of neutropenia

Handling Precautions
Avoid shaking; inspect visually for particulate matter

Pharmacokinetics
Extended half-life via pegylation

Clinical Use
Support for myelosuppressive chemotherapy

Packaging Type
Prefilled syringe or vial

Contraindications
Hypersensitivity to Pegfilgrastim or E. coliderived proteins

Visible Packaging Information
Export-quality labeled packaging

Molecular Weight
~39 kDa (Pegylated)

Strength
6 mg/0.6 ml

Route of Administration
Subcutaneous

Preservative
Preservative-free

Disposal
Dispose of in accordance with biohazard regulations

About Pegfilgrastim Injection

Spotlight on this hot-selling Pegfilgrastim Injection: an exclusive formulation for oncology supportive care. Crafted as a crowning solution, this ineffable recombinant human granulocyte colony-stimulating factor is noble in its advanced, long-acting 6 mg/0.6 ml strength. Presented as a preservative-free, ready-to-use prefilled syringe or vial, and featuring a clear, colorless, odorless solution, it ensures precise subcutaneous administration. The pegylated molecule offers an extended half-life, supporting chemotherapy-induced neutropenia recovery. Fully USP-compliant, export-quality packaging guarantees global distribution. Store refrigerated; disposal per biohazard protocols. Distributed by India's premier exporter and supplier.

Application and Surface Coverage

Pegfilgrastim Injection's primary surface of application is subcutaneous tissue, offering a targeted effect directly into the body's underlying fat layer. Its use extends across oncology centers and hospitals where prevention of chemotherapy-induced neutropenia is essential. The clear, colorless solution applies smoothly for effective stimulation of neutrophil proliferation. Additional applications may include supportive care in various myelosuppressive therapy protocols, ensuring patient safety across diverse clinical settings leveraging its noble pharmacological profile.

Packaging Details, Sample Accessibility, and Supply Capability

Our Pegfilgrastim Injection comes in export-quality labeled prefilled syringes or vials, designed for efficiency and reliability. Samples are available upon request, offering opportunities to evaluate efficacy before committing to expenditure. With robust supply ability, each order can be shipped quickly to meet global demand with minimal additional charge. The packaging supports safe transit, visible labeling details, and compliance with regulatory norms, upholding the crowning reputation of this exclusive oncology product.

FAQ's of Pegfilgrastim Injection:

Q: How should Pegfilgrastim Injection be stored before use?

A: Pegfilgrastim Injection must be stored refrigerated at 2C-8C and should not be frozen. Keep the product in its original packaging until ready for use to protect it from light.

Q: What is the main benefit of using Pegfilgrastim during chemotherapy?

A: Pegfilgrastim Injection is designed to reduce the duration and incidence of neutropenia in patients undergoing myelosuppressive chemotherapy, helping support immune recovery and minimize infection risks.

Q: When is Pegfilgrastim Injection contraindicated?

A: This medication is contraindicated in individuals with known hypersensitivity to Pegfilgrastim, E. coli-derived proteins, or any of its ingredients. It is important to review the patient's allergy history before administration.

Q: What application surface is recommended for this injection?

A: Pegfilgrastim should be administered via subcutaneous injection, typically in the upper arm, thigh, or abdomen, as these areas provide suitable absorption and comfort for patients.

Q: What precautions should be observed during handling and disposal?

A: Pegfilgrastim Injection should not be shaken and must be visually inspected for particulate matter prior to use. Dispose of all materials in accordance with biohazard waste regulations after administration.

Q: How does the supply process work and are samples available?

A: Samples can be provided for evaluation. Following expenditure approval, orders are shipped with clear labeling to meet regulatory standards, and efficient supply ensures timely global delivery.

Tell us about your requirement